Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Update on osteoporosis therapy Borges JL; Bilezikian JPArq Bras Endocrinol Metabol 2006[Aug]; 50 (4): 755-63Osteoporosis is a skeletal disorder characterized by compromised bone strength that predisposes a person to increased fracture risk. Fractures are often associated with increased morbidity, higher mortality, loss of function and even psychological consequences. Pharmacotherapeutic interventions (e.g., bisphosphonates, selective estrogen receptor modulators, calcitonin, and teriparatide) in women with postmenopausal osteoporosis provide substantial reduction in fracture risk over and above risk reduction with calcium and vitamin D supplementation alone. The importance of nutritional support along with an appropriate exercise regimen, avoiding smoking and excessive alcohol use is to be emphasized along with the pharmacologic approach to osteoporosis. Despite the effectiveness of therapy with pharmacologic agents, most patients who start therapy do not remain on treatment for more than 1 year.|Accidental Falls/prevention & control[MESH]|Bone Density Conservation Agents/pharmacology/*therapeutic use[MESH]|Bone Density/drug effects[MESH]|Calcium, Dietary/administration & dosage[MESH]|Dietary Supplements[MESH]|Exercise[MESH]|Female[MESH]|Fractures, Bone/*prevention & control[MESH]|Humans[MESH]|Long-Term Care[MESH]|Male[MESH]|Osteoporosis, Postmenopausal/prevention & control[MESH]|Osteoporosis/*drug therapy/prevention & control[MESH]|Risk Factors[MESH]|Selective Estrogen Receptor Modulators/*therapeutic use[MESH]|Vitamin D/administration & dosage[MESH] |